HCA - HCA Healthcare, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$527.45
DETAILS
HIGH:
$635.00
LOW:
$436.00
MEDIAN:
$530.00
CONSENSUS:
$527.45
UPSIDE:
33.85%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Halvorsen | 1,075,133 | $508.8M | 1.4% | +75,953 | INCREASED |
| Dalio | 173,801 | $82.2M | 0.4% | -155,506 | DECREASED |
| Greenblatt | 59,339 | $28.1M | 0.1% | +10,127 | INCREASED |
| Cooperman | 49,935 | $23.6M | 0.0% | +4,816 | INCREASED |
| Wood | 10,000 | $4.7M | 0.0% | -5,800 | DECREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-07 | Marks Mike A | officer: EVP and CFO | G-Gift | 3,336 | -- | -- |
| 2026-04-28 | MICHELSON MICHAEL W | director | A-Award | 925 | -- | -- |
| 2026-04-28 | DEPARLE NANCY ANN | director | A-Award | 509 | -- | -- |
| 2026-04-28 | Frist William R | director, 10 percent owner: | A-Award | 809 | -- | -- |
| 2026-04-28 | FRIST THOMAS F III | director, 10 percent owner: | A-Award | 1,041 | -- | -- |
| 2026-04-28 | Smith Andrea B | director | A-Award | 509 | -- | -- |
| 2026-04-28 | Riley Wayne Joseph | director | A-Award | 509 | -- | -- |
| 2026-04-28 | CHIDSEY JOHN | director | A-Award | 809 | -- | -- |
| 2026-04-28 | Johnston Hugh F | director | A-Award | 809 | -- | -- |
| 2026-02-13 | McAlevey Michael R | officer: EVP & Chief Legal & Admin Off. | M-Exempt | 5,000 | $236.61 | $1.2M |
| 2026-02-13 | McAlevey Michael R | officer: EVP & Chief Legal & Admin Off. | F-InKind | 3,306 | $540.29 | $1.8M |
| 2026-02-18 | McAlevey Michael R | officer: EVP & Chief Legal & Admin Off. | SELL | 1,694 | $533.37 | $904K |
| 2026-02-10 | Foster Jon M | officer: EVP and COO | F-InKind | 5,888 | $502.05 | $3.0M |
| 2026-02-10 | Marks Mike A | officer: EVP and CFO | F-InKind | 1,690 | $502.05 | $848K |
| 2026-02-10 | Marks Mike A | officer: EVP and CFO | A-Award | 5,026 | -- | -- |
| 2026-02-10 | Rossitto Erica | officer: SVP & Chief Nurse Executive | F-InKind | 418 | $502.05 | $210K |
| 2026-02-10 | McAlevey Michael R | officer: EVP & Chief Legal & Admin Off. | A-Award | 8,372 | -- | -- |
| 2026-02-10 | Cuffe Michael S. | officer: EVP and Chief Clinical Officer | F-InKind | 3,501 | $502.05 | $1.8M |
| 2026-02-10 | Wyatt Christopher F. | officer: SVP & Controller | A-Award | 3,350 | -- | -- |
| 2026-02-10 | Berres Jennifer | officer: SVP & Chief Human Res. Officer | F-InKind | 2,515 | $502.05 | $1.3M |
| 2026-02-11 | Wyatt Christopher F. | officer: SVP & Controller | SELL | 4,000 | $505.00 | $2.0M |
| 2026-02-10 | Wyatt Christopher F. | officer: SVP & Controller | F-InKind | 1,034 | $502.05 | $519K |
| 2026-02-10 | HAZEN SAMUEL N | director, officer: CEO | A-Award | 54,934 | -- | -- |
| 2026-02-11 | Berres Jennifer | officer: SVP & Chief Human Res. Officer | SELL | 4,010 | $526.16 | $2.1M |
| 2026-02-10 | Foster Jon M | officer: EVP and COO | A-Award | 15,696 | -- | -- |